Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiqing Lu

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Virological Methods|February 16, 2010
Assessment of the susceptibility of mutant HIV-1 to antiviral agentsYing-Jie Wang, Philip M McKenna, Renee Hrin, et al.
Viruses|October 28, 2023
A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization AssayJiajie Wei, Scott Radcliffe, Amanda Pirrone, et al.
Protein Expression and Purification|January 12, 2010
Purification of untagged HIV-1 reverse transcriptase by affinity chromatographyMeiqing Lu, Winnie Ngo, Ye Mei, et al.
Endocrinology|May 22, 2002
Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonistsDavid L Gerhold, Franklin Liu, Guoqiang Jiang, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitorsMing-Tain Lai, Meiqing Lu, Peter J Felock, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitorMeiqing Lu, Peter J Felock, Vandna Munshi, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2014
In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitorMing-Tain Lai, Meizhen Feng, Jean-Pierre Falgueyret, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)Zhijian Zhao, Scott E Wolkenberg, Philip E J Sanderson, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Science Translational Medicine|February 22, 2023
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1Carl J Balibar, Daniel J Klein, Beata Zamlynny, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Virological Methods|February 16, 2010
Assessment of the susceptibility of mutant HIV-1 to antiviral agentsYing-Jie Wang, Philip M McKenna, Renee Hrin, et al.
Viruses|October 28, 2023
A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization AssayJiajie Wei, Scott Radcliffe, Amanda Pirrone, et al.
Protein Expression and Purification|January 12, 2010
Purification of untagged HIV-1 reverse transcriptase by affinity chromatographyMeiqing Lu, Winnie Ngo, Ye Mei, et al.
Endocrinology|May 22, 2002
Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonistsDavid L Gerhold, Franklin Liu, Guoqiang Jiang, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitorsMing-Tain Lai, Meiqing Lu, Peter J Felock, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitorMeiqing Lu, Peter J Felock, Vandna Munshi, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2014
In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitorMing-Tain Lai, Meizhen Feng, Jean-Pierre Falgueyret, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)Zhijian Zhao, Scott E Wolkenberg, Philip E J Sanderson, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Science Translational Medicine|February 22, 2023
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1Carl J Balibar, Daniel J Klein, Beata Zamlynny, et al.
Pageof 4